VeriMomrhodiola rosea root extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications found (no H360/H361) and no authoritative safety assessments (CIR/SCCS) indicating reproductive hazard. Peer‑reviewed literature on Rhodiola rosea and major constituents (salidroside/rosavin) does not report clear teratogenicity or human reproductive effects, so hazard and mechanism are scored 0. Topical cosmetic use would be expected to result in low but measurable dermal exposure, so exposure scored 1 (low). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard reports), PubChem/CosIng/ECHA dossiers (no regulatory reproductive flags).
Pregnancy-safe products containing rhodiola rosea root extract
Related ingredients
Frequently asked questions
- rhodiola rosea root extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications found (no H360/H361) and no authoritative safety assessments (CIR/SCCS) indicating reproductive hazard. Peer‑reviewed literature on Rhodiola rosea and major constituents (salidroside/rosavin) does not report clear teratogenicity or human reproductive effects, so hazard and mechanism are scored 0. Topical cosmetic use would be expected to result in low but measurable dermal exposure, so exposure scored 1 (low). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard reports), PubChem/CosIng/ECHA dossiers (no regulatory reproductive flags).
- rhodiola rosea root extract est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no authoritative or peer‑reviewed evidence of reproductive or lactation toxicity; no harmonised CLP reproductive classification. Dermal topical use implies low measurable exposure; breastfeeding exposure via topical maternal use is likely low. Sources: PubMed, ECHA Annex VI, PubChem, CosIng.
- rhodiola rosea root extract est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental toxicity evidence was identified. Mechanistic concerns not demonstrated. Because infant skin has higher absorption and surface‑area‑to‑weight, exposure score is increased: adult topical exposure judged low (1) so infant exposure increased by +1 to 2 (moderate). Sources: PubMed, CosIng, ECHA dossiers, EWG.
- Comment VeriMom évalue-t-il rhodiola rosea root extract ?
- VeriMom évalue rhodiola rosea root extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à rhodiola rosea root extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à rhodiola rosea root extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.